Charles A. Deignan - 08 Jan 2025 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
Chief Financial Officer
Signature
/s/ Charles Deignan
Issuer symbol
CLSD
Transactions as of
08 Jan 2025
Net transactions value
$0
Form type
4
Filing time
10 Jan 2025, 16:30:10 UTC
Previous filing
19 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLSD Employee Stock Option (right to buy) Award $0 +200,000 $0.000000 200,000 08 Jan 2025 Common Stock 200,000 $0.9700 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares underlying this option vest on January 8, 2026 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such vesting date.